Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2012
Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strainsMasashi Shingai, Olivia K Donau, Stephen D Schmidt, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 22, 2007
Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulenceIvona V Pandrea, Rajeev Gautam, Ruy M Ribeiro, et al.Plos Pathogens|March 6, 2018
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infectionsKshitij Wagh, Michael S Seaman, Marshall Zingg, et al.Nature|April 28, 2016
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challengesRajeev Gautam, Yoshiaki Nishimura, Amarendra Pegu, et al.JCI Insight|July 24, 2023
T cell activation is insufficient to drive SIV disease progressionCristian Apetrei, Thaidra Gaufin, Egidio Brocca-Cofano, et al.Elife|October 21, 2020
A broadly neutralizing macaque monoclonal antibody against the HIV-1 V3-Glycan patchZijun Wang, Christopher O Barnes, Rajeev Gautam, et al.Science Translational Medicine|July 31, 2015
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infectionTakuya Yamamoto, Rebecca M Lynch, Rajeev Gautam, et al.Nature|March 15, 2017
Early antibody therapy can induce long-lasting immunity to SHIVYoshiaki Nishimura, Rajeev Gautam, Tae-Wook Chun, et al.Science Translational Medicine|November 24, 2021
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 EnvAmelia Escolano, Harry B Gristick, Rajeev Gautam, et al.Nature Medicine|December 10, 2021
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaquesPeng Zhang, Elisabeth Narayanan, Qingbo Liu, et al.Pageof 5